Variables | PTC (n = 112) | P | |
---|---|---|---|
HT absence (n = 77) | HT presence (n = 35) | ||
Age (year, mean ± sd) | 43.64 ± 11.49 | 42.06 ± 13.76 | 0.528 |
Gender [n(%)] | 0.751 | ||
Male | 9 (11.69%) | 3 (8.60%) | |
Female | 68 (88.31%) | 32 (91.40%) | |
Tumor size (cm, mean ± sd) | 1.28 ± 0.72 | 1.09 ± 0.50 | 0.161 |
Multifocality [n(%)] | 0.674 | ||
Positive | 27 (35.06%) | 14 (40.00%) | |
Negative | 50 (64.94%) | 21 (60.00%) | |
TSH (mIU/L, mean ± sd) | 2.43 ± 1.45 | 3.11 ± 1.75 | 0.034 |
Anti-TGAb | 24.27 ± 13.55 | 173.17 ± 137.53 | < 0.001 |
TPO-Ab | 38.26 ± 15.57 | 525.44 ± 533.05 | < 0.001 |
Extrathyroidal extension [n(%)] | 0.172 | ||
Positive | 23 (29.87%) | 6 (17.14%) | |
Negative | 54 (70.13%) | 29 (82.86%) | |
CLNM [n(%)] | 0.834 | ||
Positive | 30 (38.96%) | 15 (42.86%) | |
Negative | 47 (61.04%) | 20 (57.14%) | |
TNM stage 8th [n(%)] | 0.533 | ||
I, II | 76 (98.68%) | 34 (97.14%) | |
III, IV | 1 (1.32%) | 1 (2.86%) |